Breathing support for premature babies with lung distress
Part of Lungs & breathing, Women’s health & pregnancy clinical trials.
This Phase 3 trial tests whether InfasurfAero™ (a type of surfactant given as aerosol) works better than a sham treatment in preterm babies with respiratory distress syndrome (RDS). It aims to improve breathing in the first hours of life for babies who need CPAP.
Summary written for real people, not researchers, by Clin2.
Who can take part
- A parent/legal guardian can sign consent for the baby
- Baby was born between 29 and 35 weeks of pregnancy
- Birthweight is between 1,000 and 3,500 grams
- Baby is between 1 and 6 hours old when enrolled
- Baby has RDS from surfactant deficiency and needs CPAP support
- Baby’s breathing severity score (RSS) is between 1.25 and 2.4
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if giving surfactant (a natural substance that helps lungs stay open) through a special airway device can help late preterm and early term infants with breathing problems. The goal is to see if this approach works better than current methods without needing a breathing tube.
This study looks at different ways doctors give a life-saving medication called surfactant to premature babies who are struggling to breathe. Researchers want to understand which delivery methods work best and help improve care.
This study compares two ways of giving surfactant (a natural substance that helps lungs stay open) to premature babies who need extra breathing support. It aims to find which method works better and is safer for infants born at 29 to 36 weeks.
This trial tests whether giving surfactant (a substance that helps lungs stay open) to premature babies with Respiratory Distress Syndrome (RDS) through a mask on the throat (supraglottic airway) is safe and effective. It may be an option for babies who need extra oxygen but are not on a breathing tube.
This study tests a new medicine called APC-0101, a type of surfactant, for premature babies with breathing problems (respiratory distress syndrome). It may help their lungs work better and reduce the need for more breathing support.
This trial compares two types of surfactant (Calfactant and Poractant Alfa) given through a less invasive method to very premature babies with breathing problems. It aims to see if one works better at helping them breathe without needing a breathing tube.
Hear when a new Respiratory Distress Syndrome (Neonatal) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.